Therapeutic applications of toll-like receptors (TLRs) agonists in AML

被引:3
|
作者
Peng, Ye [1 ]
Wang, Yanzhong [2 ]
Wang, Manling [1 ]
Lan, Jianping [1 ]
Chen, Yirui [1 ]
机构
[1] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Dept Hematol, 58 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Clin Lab, Sch Med, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2022年 / 24卷 / 12期
基金
中国国家自然科学基金;
关键词
AML; TLR; Leukemia; Immunotherapy; Hematological malignancy; SQUAMOUS-CELL CARCINOMA; ACUTE MYELOID-LEUKEMIA; DC MATURATION; PHASE-I; CANCER; ACTIVATION; TOLL-LIKE-RECEPTOR-2; EXPRESSION; RESISTANCE; INDUCTION;
D O I
10.1007/s12094-022-02917-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myeloid leukemia (AML) is an aggressive type of blood cancer affecting bone marrow (BM). In AML, hematopoietic precursors are arrested in the early stages of development and are defined as the presence of >= 20% blasts (leukemia cells) in the BM. Toll-like receptors (TLR) are major groups of pattern recognition receptors expressed by almost all innate immune cells that enable them to detect a wide range of pathogen-associated molecular patterns and damage-associated molecular patterns to prime immune responses toward adaptive immunity. Because TLRs are commonly expressed on transformed immune system cells (ranging from blasts to memory cells), they can be a potential option for developing efficient clinical alternatives in hematologic tumors. This is because several in vitro and in vivo investigations have demonstrated that TLR signaling increased the immunogenicity of AML cells, making them more vulnerable to T cell-mediated invasion. This study aimed to review the current knowledge in this field and provide some insight into the therapeutic potentials of TLRs in AML.
引用
收藏
页码:2319 / 2329
页数:11
相关论文
共 50 条
  • [31] The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)
    Behzadi, Elham
    Behzadi, Payam
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2016, 69 (04) : 404 - 410
  • [32] Activation of mammalian Toll-like receptors by endogenous agonists
    Johnson, GB
    Brunn, GJ
    Platt, JL
    CRITICAL REVIEWS IN IMMUNOLOGY, 2003, 23 (1-2) : 15 - 44
  • [33] Toll-like receptors and diabetes: a therapeutic perspective
    Dasu, Mohan R.
    Ramirez, Sandra
    Isseroff, Roslyn R.
    CLINICAL SCIENCE, 2012, 122 (5-6) : 203 - 214
  • [34] Toll-like receptors as therapeutic targets in autoimmunity
    Ronnblom, Lars
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (01): : 63 - 64
  • [35] Toll-like receptors as therapeutic targets for cancer
    Holldack, Johanna
    DRUG DISCOVERY TODAY, 2014, 19 (04) : 379 - 382
  • [36] Toll-like receptors involved in the response to microbial pathogens: Development of agonists for toll-like receptor 9
    Schetter, C
    Vollmer, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 204 - 210
  • [37] Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in Keloid Scars
    Bagabir, Rania A.
    Syed, Farhatullah
    Rautemaa, Riina
    McGrouther, Duncan Angus
    Paus, Ralf
    Bayat, Ardeshir
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (10) : 2128 - 2130
  • [38] The Janus face of Bartonella quintana recognition by Toll-like receptors (TLRs): a review
    Matera, Giovanni
    Liberto, Maria Carla
    Joosten, Leo A. B.
    Vinci, Maria
    Quirino, Angela
    Pulicari, Maria Concetta
    Kullberg, Bart Jan
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    Foca, Alfredo
    EUROPEAN CYTOKINE NETWORK, 2008, 19 (03) : 113 - 118
  • [39] Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model
    Bakopoulos, Anargyros
    Kapelouzou, Alkistis
    Tsilimigras, Diamantis I.
    Katsimpoulas, Michalis
    Schizas, Dimitrios
    Aravanis, Chrysostomos
    Balafas, Evaggelos
    Mavroidis, Manolis
    Pavlakis, Kitty
    Machairas, Anastasios
    Liakakos, Theodore
    PLOS ONE, 2017, 12 (11):
  • [40] The expression of Toll-Like Receptors (TLRs) in testicular cancer: A case control study
    Shapouri, Farnaz
    Saeidi, Shaghayegh
    Kakhki, Sara Ashrafi
    Pouyan, Omid
    Amirchaghmaghi, Elham
    Aflatoonian, Reza
    IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE, 2013, 11 (11) : 919 - 924